3TIZ
CDK2 in complex with NSC 111848
3TIZ の概要
エントリーDOI | 10.2210/pdb3tiz/pdb |
関連するPDBエントリー | 3TI1 3TIY |
分子名称 | Cyclin-dependent kinase 2, 1-{(E)-[(4-hydroxyphenyl)imino]methyl}naphthalen-2-ol, 1,2-ETHANEDIOL, ... (4 entities in total) |
機能のキーワード | protein kinase, allosteric ligand, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Cytoplasm, cytoskeleton, centrosome: P24941 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 34736.32 |
構造登録者 | |
主引用文献 | Martin, M.P.,Alam, R.,Betzi, S.,Ingles, D.J.,Zhu, J.Y.,Schonbrunn, E. A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2. Chembiochem, 13:2128-2136, 2012 Cited by PubMed Abstract: In an attempt to identify novel small-molecule ligands of cyclin-dependent kinase 2 (CDK2) with potential as allosteric inhibitors, we have devised a robust and cost-effective fluorescence-based high-throughput screening assay. The assay is based on the specific interaction of CDK2 with the extrinsic fluorophore 8-anilino-1-naphthalene sulfonate (ANS), which binds to a large allosteric pocket adjacent to the ATP site. Hit compounds that displace ANS directly or indirectly from CDK2 are readily classified as ATP site binders or allosteric ligands through the use of staurosporine, which blocks the ATP site without displacing ANS. Pilot screening of 1453 compounds led to the discovery of 12 compounds with displacement activities (EC(50) values) ranging from 6 to 44 μM, all of which were classified as ATP-site-directed ligands. Four new type I inhibitor scaffolds were confirmed by X-ray crystallography. Although this small compound library contained only ATP-site-directed ligands, the application of this assay to large compound libraries has the potential to reveal previously unrecognized chemical scaffolds suitable for structure-based design of CDK2 inhibitors with new mechanisms of action. PubMed: 22893598DOI: 10.1002/cbic.201200316 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.02 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード